Anthony Coates

Prof. Anthony Coates

orcid

Research Focus & Metrics

Academic Career Length

47Years (1980-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 December 2013 in The Lancet Infectious Diseases
Verified
Journal Article
Closed access
RLRamanan Laxminarayan
Ramanan Laxminarayan
ADAdriano Duse
Adriano Duse
CWChand Wattal
Chand Wattal
AZAnita K M Zaidi
Anita K M Zaidi
HWHeiman F L Wertheim
Heiman F L Wertheim
OCOtto Cars
Otto Cars

1 November 2002 in Nature Reviews Drug Discovery
Verified
Journal Article
Closed access
ACAnthony Coates
Anthony Coates
YHYanmin Hu
Yanmin Hu
RBRichard Bax
Richard Bax
CPClive Page
Clive Page

6 April 2011 in British Journal of Pharmacology
Verified
Journal Article
Closed access
PDF file
ACAnthony Coates
Anthony Coates
GHGerry Halls
Gerry Halls
YHYanmin Hu
Yanmin Hu

31 December 2015 in mBio
Verified
Journal Article
Open access
PDF file
Egija ZauraEgija Zaura
Egija Zaura
BBBernd W Brandt
Bernd W Brandt
MMM Joost Teixeira De Mattos
M Joost Teixeira De Mattos
MBMark J Buijs
Mark J Buijs
MCMartien P M Caspers
Martien P M Caspers
WCWim Crielaard
Wim Crielaard
Due to the spread of resistance, antibiotic exposure receives increasing attention. Ecological consequences for the different niches of individual microbiomes are, however, largely ignored. Here, we report the effects of widely used antibiotics (clindamycin, ciprofloxacin, amoxicillin, and minocycline) with different modes of action on the ecology of both the gut and the oral microbiomes in 66 healthy adults from the United Kingdom and Sweden in a two-center randomized placebo-controlled clinical trial. Feces and saliva were collected at baseline, immediately after exposure, and 1, 2, 4, and 12 months after administration of antibiotics or placebo. Sequences of 16S rRNA gene amplicons from all samples and metagenomic shotgun sequences from selected baseline and post-antibiotic-treatment sample pairs were analyzed. Additionally, metagenomic predictions based on 16S rRNA gene amplicon data were performed using PICRUSt. The salivary microbiome was found to be significantly more robust, whereas the antibiotics negatively affected the fecal microbiome: in particular, health-associated butyrate-producing species became strongly underrepresented. Additionally, exposure to different antibiotics enriched genes associated with antibiotic resistance. In conclusion, healthy individuals, exposed to a single antibiotic treatment, undergo considerable microbial shifts and enrichment in antibiotic resistance in their feces, while their salivary microbiome composition remains unexpectedly stable. The health-related consequences for the gut microbiome should increase the awareness of the individual risks involved with antibiotic use, especially in a (diseased) population with an already dysregulated microbiome. On the other hand, understanding the mechanisms behind the resilience of the oral microbiome toward ecological collapse might prove useful in combating microbial dysbiosis elsewhere in the body. IMPORTANCE Many health care professionals use antibiotic prophylaxis strategies to prevent infection after surgery. This practice is under debate since it enhances the spread of antibiotic resistance. Another important reason to avoid nonessential use of antibiotics, the impact on our microbiome, has hardly received attention. In this study, we assessed the impact of antibiotics on the human microbial ecology at two niches. We followed the oral and gut microbiomes in 66 individuals from before, immediately after, and up to 12 months after exposure to different antibiotic classes. The salivary microbiome recovered quickly and was surprisingly robust toward antibiotic-induced disturbance. The fecal microbiome was severely affected by most antibiotics: for months, health-associated butyrate-producing species became strongly underrepresented. Additionally, there was an enrichment of genes associated with antibiotic resistance. Clearly, even a single antibiotic treatment in healthy individuals contributes to the risk of resistance development and leads to long-lasting detrimental shifts in the gut microbiome.

1 January 2008 in Journal of Allergy and Clinical Immunology
Verified
Journal Article
Closed access
Mei WangMei Wang
Mei Wang
CKCaroline Karlsson
Caroline Karlsson
COCrister Olsson
Crister Olsson
IAIngegerd Adlerberth
Ingegerd Adlerberth
AWAgnes E. Wold
Agnes E. Wold
SASiv Ahrné
Siv Ahrné

1 August 2007 in Journal of Allergy and Clinical Immunology
Verified
Journal Article
Closed access
IAIngegerd Adlerberth
Ingegerd Adlerberth
DSDavid P. Strachan
David P. Strachan
PMPaolo M. Matricardi
Paolo M. Matricardi
SASiv Ahrné
Siv Ahrné
LOLia Orfei
Lia Orfei
AWAgnes E. Wold
Agnes E. Wold